Kamada (KMDA) Current Assets (2012 - 2026)

Kamada (KMDA) posted quarterly Current Assets of $199.2 million for Q1 2026, up 5.69% year-on-year from $188.5 million in Q1 2025, and up 3.19% on a QoQ basis from $193.1 million in Q4 2025.

Kamada (KMDA) Current Assets (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Current Assets for 13 consecutive years, with $199.2 million the latest figure, recorded in Q1 2026.

  • Quarterly Current Assets rose 5.69% year-over-year to $199.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $199.2 million (up 5.69% YoY) and the FY2025 annual result came in at $193.1 million, up 4.73% from the prior year.
  • Current Assets improved to $199.2 million in Q1 2026 per KMDA's latest filing, from $193.1 million in the prior quarter.
  • Over the last five years, Current Assets for KMDA reached as high as $199.2 million in Q1 2026 and fell as low as $131403.0 in Q1 2023.
  • A 5-year average of $144.5 million and a median of $164.4 million in 2024 frame the typical range for Current Assets.
  • Annual changes were most pronounced in 2022 — Current Assets tumbled 99.92% — and 2024, when it soared 119994.67%.
  • Year by year, Current Assets stood at $139.0 million in 2022, then gained by 22.27% to $170.0 million in 2023, then climbed by 8.46% to $184.3 million in 2024, then gained by 4.73% to $193.1 million in 2025, then grew by 3.19% to $199.2 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $199.2 million, $193.1 million, and $192.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.05 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.71 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 6.47 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 19.71 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 2.87 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 53.60 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 10.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.44 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.58 Bn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 199.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 199.24 Mn
Dec 31, 2025 193.08 Mn
Sep 30, 2025 192.73 Mn
Jun 30, 2025 183.27 Mn
Mar 31, 2025 188.50 Mn
Dec 31, 2024 184.35 Mn
Sep 30, 2024 164.41 Mn
Jun 30, 2024 166.43 Mn
Mar 31, 2024 157.81 Mn
Dec 31, 2023 169.96 Mn
Sep 30, 2023 153.15 Mn
Jun 30, 2023 129.68 Mn
Mar 31, 2023 131,403.00
Dec 31, 2022 139.01 Mn
Sep 30, 2022 135,162.00
Jun 30, 2022 118.60 Mn
Mar 31, 2022 116.16 Mn
Dec 31, 2021 130.04 Mn
Sep 30, 2021 178.94 Mn
Jun 30, 2021 179.35 Mn